Skip to main navigation Skip to search Skip to main content

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North central cancer treatment group study N0177

  • Paul D. Brown
  • , Sunil Krishnan
  • , Jann N. Sarkaria
  • , Wenting Wu
  • , Kurt A. Jaeckle
  • , Joon H. Uhm
  • , Francois J. Geoffroy
  • , Robert Arusell
  • , Gaspar Kitange
  • , Robert B. Jenkins
  • , John W. Kugler
  • , Roscoe F. Morton
  • , Kendrith M. Rowland
  • , Paul Mischel
  • , William H. Yong
  • , Bernd W. Scheithauer
  • , David Schiff
  • , Caterina Giannini
  • , Jan C. Buckner

Research output: Contribution to journal › Article › peer-review

242   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North central cancer treatment group study N0177'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science